269 related articles for article (PubMed ID: 19624862)
1. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].
Zhao Y; Deng L; Cao Y; Ma B; Li Y; Xu J; Li H; Huang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):111-117. PubMed ID: 38322531
[TBL] [Abstract][Full Text] [Related]
4. [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].
Kang XM; Zhang QY; Tong DD; Zhao W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):730-3. PubMed ID: 16152834
[TBL] [Abstract][Full Text] [Related]
5. [Anti-angiogenic effects of low-dose gemcitabine combined with ginsenoside Rg3 on mouse Lewis lung carcinoma].
Huang X; Hou M; Yi C; Song H
Zhongguo Fei Ai Za Zhi; 2006 Apr; 9(2):132-6. PubMed ID: 21144297
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model.
Zhou S; Yang Y; Yang Y; Tao H; Li D; Zhang J; Jiang G; Fang J
PLoS One; 2013; 8(7):e68589. PubMed ID: 23874680
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma.
Zhang Q; Kang X; Zhao W
Biochem Biophys Res Commun; 2006 Apr; 342(3):824-8. PubMed ID: 16499874
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
Tang YC; Zhang Y; Zhou J; Zhi Q; Wu MY; Gong FR; Shen M; Liu L; Tao M; Shen B; Gu DM; Yu J; Xu MD; Gao Y; Li W
Int J Oncol; 2018 Jan; 52(1):127-138. PubMed ID: 29115601
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
Geng L; Fan J; Gao QL; Yu J; Hua BJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):496-501. PubMed ID: 27318914
[TBL] [Abstract][Full Text] [Related]
11. Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation.
Li Y; Wang Y; Niu K; Chen X; Xia L; Lu D; Kong R; Chen Z; Duan Y; Sun J
Oncotarget; 2016 Oct; 7(43):70535-70545. PubMed ID: 27655708
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of Bifidobacterium infantis-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice.
Li ZJ; Zhu H; Ma BY; Zhao F; Mao SH; Liu TG; He JP; Deng LC; Yi C; Huang Y
BMC Cancer; 2012 Apr; 12():155. PubMed ID: 22536942
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ
Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799
[TBL] [Abstract][Full Text] [Related]
14. Different combination schedules of gemcitabine with endostar affect antitumor efficacy.
Peng XC; Qiu M; Wei M; Tan BX; Ge J; Zhao Y; Chen Y; Cheng K; Zhou Y; Wu Y; Gong FM; Li Q; Xu F; Bi F; Liu JY
Cancer Chemother Pharmacol; 2012 Jan; 69(1):239-46. PubMed ID: 21706279
[TBL] [Abstract][Full Text] [Related]
15. Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.
Hou JM; Liu JY; Yang L; Zhao X; Tian L; Ding ZY; Wen YJ; Niu T; Xiao F; Lou YY; Tan GH; Deng HX; Li J; Yang JL; Mao YQ; Kan B; Wu Y; Li Q; Wei YQ
Oncology; 2005; 69(1):81-7. PubMed ID: 16088235
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng.
Mochizuki M; Yoo YC; Matsuzawa K; Sato K; Saiki I; Tono-oka S; Samukawa K; Azuma I
Biol Pharm Bull; 1995 Sep; 18(9):1197-202. PubMed ID: 8845804
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
Zou J; Su H; Zou C; Liang X; Fei Z
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine].
Mei K; Tian L; Wei YQ; Li J; Wen YJ; Kan B; Deng HX
Ai Zheng; 2005 Apr; 24(4):397-402. PubMed ID: 15820059
[TBL] [Abstract][Full Text] [Related]
19. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
Kunnumakkara AB; Guha S; Krishnan S; Diagaradjane P; Gelovani J; Aggarwal BB
Cancer Res; 2007 Apr; 67(8):3853-61. PubMed ID: 17440100
[TBL] [Abstract][Full Text] [Related]
20. Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model.
Zheng SJ; Zheng SP; Huang FY; Jiao CL; Wu RL
World J Gastroenterol; 2007 May; 13(17):2484-9. PubMed ID: 17552033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
